G I Rodriguez
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Neutropenia and Cancer Infections, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Cancer-related Molecular Pathways
Most-Cited Works
- A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.(2000)
- → Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.(1996)352 cited
- → Phase I and pharmacokinetic trial of weekly CPT-11.(1993)303 cited
- Erratum: A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (Clinical Cancer Research (2000) 6 (798-806))(2000)
- → Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.(1997)75 cited
- A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)(1999)
- → Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours(1998)61 cited
- → Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks(2001)44 cited
- → A Phase II Trial of DaunoXome, Liposome- Encapsulated Daunorubicin, in Patients with Metastatic Adenocarcinoma of the Colon(1994)38 cited
- Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.(1998)